Clinical Trial Update: Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study [NA]

View source ↗

Summary

A pilot study evaluating fecal microbiota transplantation in patients with lymphoma undergoing CAR-T therapy or allogeneic stem cell transplant; the trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lymphoma Receiving CAR-T Therapy | NA | Status: NOT_YET_RECRUITING